1. Home
  2. PZG vs GOSS Comparison

PZG vs GOSS Comparison

Compare PZG & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paramount Gold Nevada Corp.

PZG

Paramount Gold Nevada Corp.

HOLD

Current Price

$1.96

Market Cap

97.2M

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.48

Market Cap

101.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PZG
GOSS
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.2M
101.2M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
PZG
GOSS
Price
$1.96
$0.48
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$4.91
AVG Volume (30 Days)
1.2M
25.7M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
78.81
EPS
N/A
N/A
Revenue
$330,259.00
$114,701,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.33
52 Week High
$2.70
$3.87

Technical Indicators

Market Signals
Indicator
PZG
GOSS
Relative Strength Index (RSI) 40.60 24.40
Support Level $1.05 $0.33
Resistance Level $2.54 $0.60
Average True Range (ATR) 0.14 0.06
MACD -0.08 0.05
Stochastic Oscillator 2.86 47.70

Price Performance

Historical Comparison
PZG
GOSS

About PZG Paramount Gold Nevada Corp.

Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, the company is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. The company enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Its projects include sleeper gold, grassy mountain gold, frost project, other non-material, and others.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: